• ATMP
  • Inhaler
  • Liposomal technology
  • Lyophilization technology
  • Micro-emulsion
  • Transdermal

ELC is able to provide bespoke services in niche areas of development of specific technologies. We are able to provide formulation of finished forms of inhalers (including device), liposome formulations, transdermal patches and softgel capsule product development with mirco emulsion vehicle system.  Our team consists of scientists and regulatory experts who are able to advise on specifics of these developments as well as ATMP and Nanotechnology, from a Quality and Clinical/Preclinical perspective. Additionally, we can provide technical inputs regarding the regulatory hurdles of such specialized technologies from our team of ex-agency experts that have sat on Scientific Advise Panels  and Working Parties at a number of agencies.